Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.
about
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@en
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@nl
type
label
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@en
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@nl
prefLabel
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@en
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-term exposure to Myozyme ...... -onset Pompe disease patients.
@en
P2093
Barbara Perniconi
Catherine Caillaud
Damien Amelin
Elisa Masat
Federico Mingozzi
Francesco Puzzo
French Pompe Registry Study Group
Giuseppe Ronzitti
Kuberaka Mariampillai
Marie De Antonio
P2860
P2888
P356
10.1038/SREP36182
P407
P577
2016-11-04T00:00:00Z
P6179
1011335661